On Monday, Piper Sandler showed a positive outlook for shares of USCB Financial Holdings (NASDAQ: USCB), shifting its rating from Neutral to Overweight and boosting the price target to $20.00 from ...

On Tuesday, Piper Sandler maintained its optimistic stance on shares of Zura Bio Ltd. (NASDAQ: ZURA), reiterating an Overweight rating with a $26.00 price target. The firm's confidence in Zura Bio ...

In a report released today, Korinne Wolfmeyer from Piper Sandler maintained a Hold rating on Hims & Hers Health (HIMS – Research Report), with a price target of $21.00. The company’s shares ...

Piper Sandler initiated coverage of Camp4 Therapeutics (CAMP) with an Overweight rating and $18 price target The company is is pioneering development of regulatory RNAs as a novel therapeutic ...

Clay Stinnett, EVP and CFO will participate in the Piper Sandler 2024 East Coast Financial Services Conference to be held November 13th and 14th, and will participate in a series of meetings with ...

Piper Sandler raised the firm’s price target on Cigna (CI) to $394 from $392 and keeps an Overweight rating on the shares. The firm notes Cigna reported a pharmacy-led Q3 adjusted EPS beat and ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

If you’re on the fence about investing in Piper Sandler Companies, Lazard or Inc. because you’re not sure how they measure up, it’s important to compare them on a few factors before making your ...

GOP Rep. Marjorie Taylor Greene (Ga.) easily won reelection Tuesday, fending off a challenge from Democrat Shawn Harris, a retired Army general, in Georgia’s deep-red 14th District, Decision ...